AU2013902377A0 - A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulation - Google Patents

A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulation

Info

Publication number
AU2013902377A0
AU2013902377A0 AU2013902377A AU2013902377A AU2013902377A0 AU 2013902377 A0 AU2013902377 A0 AU 2013902377A0 AU 2013902377 A AU2013902377 A AU 2013902377A AU 2013902377 A AU2013902377 A AU 2013902377A AU 2013902377 A0 AU2013902377 A0 AU 2013902377A0
Authority
AU
Australia
Prior art keywords
immunomodulation
super
human
application
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013902377A
Inventor
Charles Reay Mackay
Di YU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Publication of AU2013902377A0 publication Critical patent/AU2013902377A0/en
Priority to JP2016522133A priority Critical patent/JP6563389B2/en
Priority to US14/392,256 priority patent/US10077301B2/en
Priority to AU2014302028A priority patent/AU2014302028B2/en
Priority to EP14817437.8A priority patent/EP3013858B1/en
Priority to ES14817437T priority patent/ES2898650T3/en
Priority to PCT/AU2014/000673 priority patent/WO2014205501A1/en
Priority to CA2915882A priority patent/CA2915882C/en
Priority to CN201480037182.8A priority patent/CN105579470B/en
Assigned to MACKAY, CHARLES, MONASH UNIVERSITY reassignment MACKAY, CHARLES Amend patent request/document other than specification (104) Assignors: MABDESIGN PTY LTD, MONASH UNIVERSITY
Priority to US16/101,976 priority patent/US10787510B2/en
Priority to US16/937,121 priority patent/US20210002362A1/en
Abandoned legal-status Critical Current

Links

AU2013902377A 2013-06-27 2013-06-27 A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulation Abandoned AU2013902377A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CN201480037182.8A CN105579470B (en) 2013-06-27 2014-06-27 IL-21 binding proteins and uses thereof
ES14817437T ES2898650T3 (en) 2013-06-27 2014-06-27 IL-21 binding proteins and uses thereof
US14/392,256 US10077301B2 (en) 2013-06-27 2014-06-27 IL-21 binding proteins
AU2014302028A AU2014302028B2 (en) 2013-06-27 2014-06-27 IL-21 binding proteins and uses thereof
EP14817437.8A EP3013858B1 (en) 2013-06-27 2014-06-27 Il-21 binding proteins and uses thereof
JP2016522133A JP6563389B2 (en) 2013-06-27 2014-06-27 IL-21 binding protein and use thereof
PCT/AU2014/000673 WO2014205501A1 (en) 2013-06-27 2014-06-27 Il-21 binding proteins and uses thereof
CA2915882A CA2915882C (en) 2013-06-27 2014-06-27 Il-21 binding proteins and uses thereof
US16/101,976 US10787510B2 (en) 2013-06-27 2018-08-13 Methods of treating cancer using an IL-21 agonist
US16/937,121 US20210002362A1 (en) 2013-06-27 2020-07-23 Il-21 binding proteins and uses thereof

Publications (1)

Publication Number Publication Date
AU2013902377A0 true AU2013902377A0 (en) 2013-07-11

Family

ID=

Similar Documents

Publication Publication Date Title
IL270218B (en) Anti-activin a antibodies and uses thereof
EP3013365A4 (en) Rm2 antigens and use thereof
IL240443A0 (en) Highly galactosylated anti-tnf-alpha antibodies and uses thereof
ZA201407927B (en) Anti-egfr antibodies and uses thereof
ZA201500887B (en) Human anti-cd27 antibodies, methods and uses
EP3026062A4 (en) Anti-pd-1 antibody and use thereof
EP3003248A4 (en) Skin care sheet and skin care article
EP3019240A4 (en) Anti-complement factor c1q antibodies and uses thereof
EP3003390A4 (en) Anti-c10orf54 antibodies and uses thereof
EP2970490A4 (en) Antibodies to mica and micb proteins
EP3071740A4 (en) Soft and durable nonwoven composite
EP3079719B8 (en) Anti-siglec-8 antibodies and methods of use thereof
EP3066470A4 (en) Humanized anti-ceacam5 antibody and uses thereof
EP3001836A4 (en) Design and use of specific regulatory t-cells to induce immune tolerance
EP2968503A4 (en) Anti-hepcidin antibodies and uses thereof
EP3178847A4 (en) Anti-tnf-alpha fully human monoclonal antibodies with low immunogenicity and application thereof
EP3047389A4 (en) Using user mood and context to advise user
EP3060253A4 (en) ANTI-Ly6E ANTIBODIES AND METHODS OF USE
EP3060724A4 (en) Improvements in and relating to couplers
IL240440A0 (en) Highly galactosylated anti-her2 antibodies and uses thereof
EP2951208A4 (en) Anti-cd83 antibodies and use thereof
EP3010934A4 (en) Antibodies to human resistin
EP2970454A4 (en) Antibodies specific to a novel epitope on cemx of human membrane-bound ige and uses thereof in treating ige-mediated diseases
AU2013902377A0 (en) A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulation
AU2014203022A1 (en) Improvements in and Relating to Packaging